Celerion Inc is categorized under Commercial Medical Research in Lincoln, NE and active since 2010.
Celerion Inc was established in 2010, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Susan Thornton, Chief Executive Officer at the company’s headquarters by writing to 621 Rose St, Lincoln, Nebraska NE 68502 or by phoning (402) 476-2811. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Celerion Inc |
| Contact Person: | Susan Thornton, Chief Executive Officer |
| Address: | 621 Rose St, Lincoln, Nebraska 68502 |
| Phone Number: | (402) 476-2811 |
| Website Address: | celerion.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2010 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417115 |
| Share This Business: |
Celerion Inc was started in 2010 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Susan Thornton, Chief Executive Officer for inquiries that concern Celerion Inc by calling the company number (402) 476-2811, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Celerion Inc can be found at the coordinates 40.794775,-96.712107 as well as the street address 621 Rose St in Lincoln, Nebraska 68502.
For its online presence, you may visit Celerion Inc’s website at celerion.com and engage with its social media outlets through on Twitter and on Facebook.